期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肺癌反义核苷酸治疗的研究进展 被引量：3

Research on anti-sense nucleotide technology in current lung cancer treatment
原文传递
导出
摘要 肺癌是全世界高发肿瘤之一，而反义寡核苷酸（ASON）作为一个简单有效的基因治疗手段已受到广泛的关注。就肺癌反义核苷酸治疗的原理、特点及在肺癌癌基因治疗方面的应用进行综述。 Lung cancer has been widely known for its highest morbidity among all tumors in this world. Anti-sense neoelitide technology is a kind of widely-recognized gene therapy for its high efficiency and practical simplicity. This essay will briefly review principles of anti-sense neoclitide technology used in treatment of lung cancer and characteristics of this technology in gene therapy of lung cancer.
作者 王巍炜（综述） 洪志鹏（审校） 李高峰（审校）
机构地区 昆明医学院第三附属医院胸外科云南省肺癌临床研究中心 昆明医学院第一附属医院胸外科
出处 《肿瘤研究与临床》 CAS 2011年第11期790-792,共3页 Cancer Research and Clinic
关键词 寡核糖核苷酸类 反义 肺肿瘤 基因 Oligoribonucleotides, antisense Lung neoplasms Genes
分类号 R512.620.5 [医药卫生—内科学]
  • 相关文献

参考文献25

  • 1Papucci L, Schiavone N, Donnini M, et al. Phosphodiester oligonucleotides inhibit mitosis and trigger apoptosis by a non- antisense p53-mediated mechanism. Antisense Nucleic Acid Drug Dev, 2002, 12: 21-31.
  • 2Stein CA, Cheng YC. Antisence oligonucleotides as therapeutic agents-is the bullet really magical. Science, 1993, 261: 1004-1010.
  • 3Smith M. Characterisation of a modified oligonucleotide together with its synthetic impurities using accurate mass measurements. Rapid Commun Mass Spectrom, 2011, 25:511-525. .
  • 4VickersTA, Koo S, Bennett CF, et al. Efficient reduction of target RNAs by small interfering RNA and RNaseH-dependent antisense agents. J Biol Chem, 2003, 278:7108-7118.
  • 5Muchmore SW, Chen J, Jakob C, et al. Crystal structure and mutagenic analysis of the inhibitor of apoptosis protein survivin. Mol Cell, 2000, 6: 173-182.
  • 6Callies S, Andr ~ V, Pate1 B. Integrated analysis of preclinical data to support the design of thFe first in man study of LY2181308, a second generation antisense oligonucleotide. Br J Clin Pharmacol, 2011, 71: 416-428.
  • 7Rudin CM, Koxloff M, Hoffman PC , et al. Phase I study of G3139,a bcl-2 antisense oligonucleotide , combined with carboplatin and etoposide in with small-cell lung cancer. J Clin Oncol, 2004, 22:1114 -1117.
  • 8贾秀红,谢绍华,李建厂,韩兆东,刘媛媛.Livin反义寡核苷酸对K562细胞增殖和凋亡的影响[J].肿瘤研究与临床,2011,23(1):34-37. 被引量：3
  • 9惠燕,黄利鸣.survivin的研究进展[J].肿瘤研究与临床,2006,18(11):787-789. 被引量：4
  • 10Shen C, Duck A, Polat B, et al. Triplex forming oligodeoxy nucleotides targeting survivin inhibitor proliferation and induce apoptosis of human lung carcinoma ceils. Cancer Gene Ther, 2003, 10: 403-410.

二级参考文献73

  • 1Cong YS, Wright WE, Shay JW. Human telornerase and its regulation. Microbiol Mol Biol Rev, 2002, 66:407-425.
  • 2Shay JW,Baichetti S.A survey of telomerase activity in human cancer.Eur J Cancer, 1997, 33:787-791.
  • 3Kyo S, Takakura M, Inoue M. Telomerase activity in cancer as a diagnostic and therapeutic target. Histol Histopathol, 2000, 15: 813-824.
  • 4Yamada K, Yajima T, Yagihashi A, et al. Role of hint, an tetomerase reverse transcriptase and telomefic-repeat binding factor proteins 1 and 2 in human hematopoietic cells. Jpn J Cancer Res, 2000, 91 : 1278 -1284.
  • 5Boussif O, Lezoualch F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci U S A, 1995, 92:7297- 7301.
  • 6Hisayasu S, Miyauehi M, Akiyama K, et al. In vivo targeted gene transfer into liver cells mediated by a novel galactosyl-D-lysine/D- serine copolymer. Gene Ther, 1999, 6:689-693.
  • 7Mao HQ, Roy K, Troung-Le VL, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release, 2001, 70:399-421.
  • 8Curnis F, Arrigoni G, Sacchi A, et al. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Res, 2002. 62:867-874.
  • 9Kyo S, Kanaya T, Takakura M, et al. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int J Cancer, 1999, 80:804-809.
  • 10Curnis F, Sacchi A, Borgia L, et al. Enhancement of tumor necrosis factor alpha antitumor immunotherapeutlc properties by targeted delivery to aminopeptidase N (CD13). Nat Biotechnol, 2000, 18:1185-1190.

共引文献25

同被引文献39

引证文献3

二级引证文献104

肿瘤研究与临床
2011年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部